EUVIMEDEUVIMED entdecken
Crossref

CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway

Kai Li, Jiancheng Lv, Jun Wang, Yong Wei, Yetao Zhang, Jianzhong Lin, Qingyi Zhu

International Immunopharmacology · 2024-08 · 137 · 112485

DOI: 10.1016/j.intimp.2024.112485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-08. Verfasst von Kai Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, RNA, Circular, RNA-Binding Proteins, Immunotherapy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circular RNAs (circRNAs) are gaining attention for their involvement in immune escape and immunotherapy sensitivity regulation. CircZNF609 is a well-known oncogene in various solid tumours. Our previous research revealed its role in reducing the chemosensitivity of bladder cancer (BCa) to cisplatin. However, the underlying role of circZNF609 in BCa immune escape and immunotherapy sensitivity remains unknown. We conducted BCa cells-CD8 + T cells co-culture assays, cell line-derived xenograft and patient-derived xenograft mouse models with human immune reconstitution to further confirm the role of circZNF609 in BCa immune escape and immunotherapy sensitivity. Overexpression of circZNF609 promoted BCa immune escape in vitro and in vivo. Mechanistically, circZNF609 was bound to IGF2BP2, enhancing its interaction with the 3'-untranslated region of CD36. This increased the stability of the CD36 mRNA, leading to enhanced fatty acid uptake by BCa cells and fatty acid depletion within the tumour microenvironment. Additionally, the nuclear export of circZNF609 was regulated by DDX39B. CircZNF609 promoted immune escape and suppressed BCa immunotherapy sensitivity by regulating the newly identified circZNF609/IGF2BP2/CD36 cascade. Therefore, circZNF609 holds potential as both a biomarker and therapeutic target in BCa immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsRNA, CircularRNA-Binding ProteinsImmunotherapyFatty AcidsHumansAnimalsCell Line, TumorMiceTumor EscapeTumor MicroenvironmentSignal TransductionGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysCD8-Positive T-LymphocytesDEAD-box RNA HelicasesMaleFemaleCD36 Antigens

Stichwörter der Autor:innen

Bladder cancerCD36Circular RNAIGF2BP2Immunotherapy

Substanzen

RNA, CircularRNA-Binding ProteinsIGF2BP2 protein, humanFatty AcidsCD36 protein, humanDEAD-box RNA HelicasesCD36 Antigens

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Urology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: linjianzhong82@126.com.
  • Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Urology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. Electronic addre…

Zitieren

APA

Li, K., Lv, J., Wang, J., Wei, Y., Zhang, Y., Lin, J., & Zhu, Q. (2024). CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway. International Immunopharmacology, 137, 112485. https://doi.org/10.1016/j.intimp.2024.112485

Vancouver

Li K, Lv J, Wang J, Wei Y, Zhang Y, Lin J, et al. CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway. International Immunopharmacology. 2024;137:112485. doi:10.1016/j.intimp.2024.112485

BibTeX
@article{Li2024,
  author = {Li, Kai and Lv, Jiancheng and Wang, Jun and Wei, Yong and Zhang, Yetao and Lin, Jianzhong and Zhu, Qingyi},
  title = {CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {137},
  pages = {112485},
  doi = {10.1016/j.intimp.2024.112485}
}
Kostenlos starten →